Characterization and Survival Benefit of Drug Approvals for Metastatic Prostate Cancer, 2004 to 2022.

Clin Med Insights Oncol

Division of Hematology/Oncology, Department of Medicine, University of California, Irvine Medical Center, Orange, CA, USA.

Published: February 2024

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10845988PMC
http://dx.doi.org/10.1177/11795549241227413DOI Listing

Publication Analysis

Top Keywords

characterization survival
4
survival benefit
4
benefit drug
4
drug approvals
4
approvals metastatic
4
metastatic prostate
4
prostate cancer
4
cancer 2004
4
2004 2022
4
characterization
1

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!